Skip to content

Dear Family and Friends,

Greetings! We are pleased to inform you of our transition of kidney health supplement Renadyl to a Live Biotherapeutic Product (LBP) drug category for medical reimbursement reasons. This improved version is known as US APR-2020.

Excellent and Unique Opportunity! US FDA/CBER Approved RCT To Delay Dialysis with Probiotics US-APR 2020 Phase 2B, Multi-site CKD Stage 4 (N=630) Oral and Safe Intestinal Dialysis

In this regard, if you or your friends are interested in exploring the opportunity to be a participant, in this unique clinical trial, please contact the Medical Director at

Are you interested in knowing more information?

As we proceed with clinical trials and until the launch of the product as a drug, if you are hesitant to participate you can still avail yourself the opportunity to buy our Kidney health supplement Renadyl™( directly from our online store. If any questions contact our customer service or +1.888.271.2560 (US).
With warmest regards,
Dr. Rangan
Managing Director – Kibow Biotech, Inc.
4781 West Chester Pike | Newtown Square, PA 19073 
Mobile: 215-510-3575 | Off: 610-353-5130, Ext 222 | Fax: 610-353-5110 
We have recently published our study on Longdom Publishing SL with some very positive reviews from global readers.
Please click to read:

Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV (CKD), for study details,please click to review:

Kibow Pharmaceuticals, LLC | | Phone: +1.610.353.5130